These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35505474)

  • 21. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
    Isakova J; Sovkhozova N; Vinnikov D; Goncharova Z; Talaibekova E; Aldasheva N; Aldashev A
    BMC Microbiol; 2018 Mar; 18(1):22. PubMed ID: 29566660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a Molecular Test for Detection of Mycobacterium tuberculosis Isolates Resistant to Rifampicin and Isoniazid.
    Benaissa E; Benlahlou Y; Bssaibis F; Maleb A; Elouennass M
    Clin Lab; 2022 Mar; 68(3):. PubMed ID: 35254025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso.
    Miotto P; Saleri N; Dembelé M; Ouedraogo M; Badoum G; Pinsi G; Migliori GB; Matteelli A; Cirillo DM
    BMC Infect Dis; 2009 Aug; 9():142. PubMed ID: 19715569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Xpert Mycobacterium tuberculosis/Rifampicin-Detected Rifampicin Resistance is a Suboptimal Surrogate for Multidrug-resistant Tuberculosis in Eastern Democratic Republic of the Congo: Diagnostic and Clinical Implications.
    Bisimwa BC; Nachega JB; Warren RM; Theron G; Metcalfe JZ; Shah M; Diacon AH; Sam-Agudu NA; Yotebieng M; Bulabula ANH; Katoto PDMC; Chirambiza JP; Nyota R; Birembano FM; Musafiri EM; Byadunia S; Bahizire E; Kaswa MK; Callens S; Kashongwe ZM
    Clin Infect Dis; 2021 Jul; 73(2):e362-e370. PubMed ID: 32590841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
    Niehaus AJ; Mlisana K; Gandhi NR; Mathema B; Brust JC
    PLoS One; 2015; 10(9):e0135003. PubMed ID: 26332235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of an indigenous assay for rapid molecular detection of rifampicin resistance in presumptive multidrug-resistant pulmonary tuberculosis patients.
    Gomathi NS; Singh M; Myneedu VP; Chauhan DS; Tripathy S; Sarin R; Mohan A; Bhatnagar A; Khangembam JS; Kannan T; V Rao MV; Logani J; Dey B; Gangakhedkar RR; Swaminathan S; Singh UB
    Indian J Med Res; 2020 Nov; 152(5):482-489. PubMed ID: 33707390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of genotype MTBDRplus line probe assay in detection of rifampicin and isoniazid resistance in comparison to solid culture drug susceptibility testing in a tertiary care centre of western Uttar Pradesh.
    Ahmed S; Shukla I; Fatima N; Varshney SK; Shameem M
    Indian J Med Microbiol; 2017; 35(4):568-574. PubMed ID: 29405151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns and profiles of drug resistance-conferring mutations in
    Reta MA; Maningi NE; Fourie PB
    Front Public Health; 2024; 12():1356826. PubMed ID: 38566794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Capacity of Abbott RealTi
    Hofmann-Thiel S; Molodtsov N; Duffner C; Kadyrov A; Kalmambetova G; Kabirov O; Rajabov A; Parpieva N; Sayfutdinov Z; Vogel M; Vogel H; Antonenka U; Hoffmann H
    Int J Tuberc Lung Dis; 2019 Apr; 23(4):458-464. PubMed ID: 31064625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of the GenoType
    Stephen S; Muzhizhizhi D; Dhibi N; Chidemo T; Samaneka W; Matubu TA; Hakim JG; Chirenje ZM
    Int J Mycobacteriol; 2019; 8(1):83-88. PubMed ID: 30860184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High degree of multi-drug resistance and hetero-resistance in pulmonary TB patients from Punjab state of India.
    Kumar P; Balooni V; Sharma BK; Kapil V; Sachdeva KS; Singh S
    Tuberculosis (Edinb); 2014 Jan; 94(1):73-80. PubMed ID: 24184256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of multi-drug resistance & characterization of mutations in Mycobacterium tuberculosis isolates from North- Eastern States of India using GenoType MTBDRplus assay.
    Singhal R; Myneedu VP; Arora J; Singh N; Sah GC; Sarin R
    Indian J Med Res; 2014 Oct; 140(4):501-6. PubMed ID: 25488443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the GenoType MTBDRplus assay for detection of MDR-TB in a public health laboratory in Thailand.
    Anek-Vorapong R; Sinthuwattanawibool C; Podewils LJ; McCarthy K; Ngamlert K; Promsarin B; Varma JK
    BMC Infect Dis; 2010 May; 10():123. PubMed ID: 20487550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic mutations associated with rifampicin and isoniazid resistance in MDR-TB patients in North-West India.
    Kumar P; Kumar P; Balooni V; Singh S
    Int J Tuberc Lung Dis; 2015 Apr; 19(4):434-9. PubMed ID: 25859999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and molecular characterization of multidrug-resistant M. tuberculosis in Jiangxi province, China.
    Luo D; Chen Q; Xiong G; Peng Y; Liu T; Chen X; Zeng L; Chen K
    Sci Rep; 2019 May; 9(1):7315. PubMed ID: 31086215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotype MTBDR plus assay for molecular detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis.
    Sharma S; Madan M; Agrawal C; Asthana AK
    Indian J Pathol Microbiol; 2014; 57(3):423-6. PubMed ID: 25118735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
    Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
    BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of genotype MTBDRplus in rapid detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin in a high volume laboratory in Southern China.
    Zhang L; Ye Y; Duo L; Wang T; Song X; Lu X; Ying B; Wang L
    Mol Biol Rep; 2011 Mar; 38(3):2185-92. PubMed ID: 20852939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis isolates in Morocco using GenoType
    Ennassiri W; Jaouhari S; Sabouni R; Cherki W; Charof R; Filali-Maltouf A; Lahlou O
    J Glob Antimicrob Resist; 2018 Mar; 12():197-201. PubMed ID: 28993300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surveillance and characterization of drug-resistant
    Imperiale BR; Di Giulio ÁB; Mancino MB; Zumárraga MJ; Morcillo NS
    Int J Mycobacteriol; 2019; 8(3):223-228. PubMed ID: 31512597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.